Olaparib: Difference between revisions

No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1001156/Cv/1'>
<StructureSection load='' size='340' side='right' caption='Olaparib' scene='10/1001156/Cv/1'>
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults (see [[BRCA]]). It is a PARP inhibitor, inhibiting [[Poly (ADP-ribose) polymerase|poly ADP ribose polymerase]] (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.<ref name="a7">PMID:19553641</ref> See also [https://en.wikipedia.org/wiki/Olaparib Olaparib].
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults (see [[BRCA]]). It is a PARP inhibitor, inhibiting [[Poly (ADP-ribose) polymerase|poly ADP ribose polymerase]] (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.<ref name="a7">PMID:19553641</ref> See also [https://en.wikipedia.org/wiki/Olaparib Olaparib].


Line 5: Line 5:


<scene name='10/1001156/Overall/1'>Poly [ADP-ribose] polymerase 2 in complex with Olaparib</scene> ([[4tvj]]).
<scene name='10/1001156/Overall/1'>Poly [ADP-ribose] polymerase 2 in complex with Olaparib</scene> ([[4tvj]]).
<scene name='10/1001156/Binding_site/2'>Olaparib binding site</scene>. Water molecules are shown as red spheres.


See also:
See also:
*[[Mutations in BRCA1/BARD1 RING-domain heterodimer]]
*[[Mutations in BRCA1/BARD1 RING-domain heterodimer]]
*[[Mutations in Brca1 BRCT Domains]]
*[[Mutations in Brca1 BRCT Domains]]
*[[RING Finger Domain of BRCA1 and BARD1 Heterodimer]]
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel